The Global Epinephrine Auto-injector Market to Reach Revenues of Over $2 Billion During the Period 2020 −2025 - Market Research by Arizton

News provided by

Apr 23, 2020, 09:00 ET

CHICAGO, April 23, 2020 /PRNewswire/ -- According to Arizton's recent research report, Epinephrine Auto-Injector Market - Global Outlook and Forecast 2020-2025 is expected to grow at a CAGR of approximately 9% during the period 2019−2025. This market research report includes data-driven and deep market insights on the impact of COVID-19 across geographies, segments, and vendor landscape. Leverage Arizton's market analysis to take real-time strategic business decisions and enhance your product portfolios.

Key Highlights Offered in the Report:

Globally, the epinephrine auto-injectors market is estimated to grow at a single digit rate of around 9% due to growing acceptance of epinephrine auto-injectors as emergency treatment for anaphylaxis.
Greater availability of generic version of epinephrine auto-injectors compared to branded one is expected to impact the market growth over the forecast period.
Self-administration of anaphylaxis with safe, effective, and easy to use epinephrine auto-injectors is gaining popularity globally, thus it is becoming one of the key driving factors of the global epinephrine auto-injectors market.
Many market players are focusing on several patient assistance programs to offer a wide range of disease prevention practices and patient education materials related to anaphylaxis.
North America is leading the global market and accounted for a share of around 80% in 2019, followed by Europe, APAC, Middle East & Africa, and Latin America.
Mylan is the market leader and offers innovative product line for epinephrine auto-injector.

Key Offerings:

Market Size & Forecast by Revenue | 2019−2025
Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
Market Segmentation – A detailed analysis by dosage, age group, end-user, and geography
Competitive Landscape – Profile of 3 key vendors and 6 other vendors

Get your sample today! https://www.arizton.com/market-reports/epinephrine-auto-injector-market

Epinephrine Auto-Injector Market – Segmentation

The growing incidence of anaphylaxis in adults, especially in the elderly population, is the primary factor driving the growth of the high dose segment. As epinephrine is considered as the first-line treatment for anaphylaxis, the increasing recommendation of high dose by healthcare professionals (HCP) across the globe for adult patients is fueling the growth of the segment.
In 2019, the below 6 years segment accounted for a 10% market share of the global epinephrine auto-injector market. Children in this age group are prescribed to be treated with 0.15 mg/0.1 mg dose capacity. An estimated 130% increase in emergency room visits for anaphylaxis among children aged 4 years old and younger reported between 2005 and 2014.
HCPs in hospitals & clinics are using epinephrine auto-injectors for the emergency management of anaphylaxis. The market is growing at a healthy rate on account of the high adoption of these devices by emergency departments in hospitals and clinics. The availability of skilled HCPs with knowledge and expertise also attracts many patients to hospitals and clinics.

Market Segmentation by Dosage

High
Low

Market Segmentation by Age Group

Below 6 Years
Between 6 & 12 years
Above 12 years

Market Segmentation by End-user

Hospitals & Clinics
Individuals
Others

Epinephrine Auto-Injector Market – Dynamics

Owing to the significant growth opportunity in the global epinephrine auto-injectors market, new and emerging market players are strategically focusing on the development of innovative solutions for anaphylaxis management. New product development, coupled with product innovations and R&D activities, helps new and emerging players to establish their presence, as well as enhance market growth and sustain their market position. Vendors are actively conducting clinical trials in order to gain regulatory approval in different countries. The existing epinephrine-auto injectors are mostly bigger in size that creates inconvenience while carrying such an emergency device. Also, user-friendliness or safety aspect is another drawback in existing epinephrine auto-injectors.

Key Drivers and Trends fueling Market Growth:

Vendors' Growing Focus on Patient Assistance Programs
Increasing Demand for Generic Epinephrine Auto-injectors at Pharma/Retail Stores
Rising Incidence of Anaphylaxis
Growing Demand for Self-administration of Drugs

Epinephrine Auto-Injector Market – Geography

North America dominates the epinephrine auto-injector market. The presence of a large disease population, coupled with better access to treatment for anaphylaxis, is the primary factor for its high market share. The strong presence of key vendors is also another reason for high product uptake in the region. Moreover, the rise in the anaphylactic patient pool and the launch of generic substitutes, which help to treat the condition effectively in adults and children groups, are likely to boost the growth during the forecast period. Canada is likely to experience healthy growth during the forecast period. The market in the region is dominated by branded as well as generic epinephrine auto-injectors for the treatment of anaphylactic reaction. The availability of generic epinephrine auto-injectors is abundantly high in this region.

Get your sample today! https://www.arizton.com/market-reports/epinephrine-auto-injector-market

Market Segmentation by Geography

Europe

Spain
Germany
Netherlands
France
UK

North America

US
Canada

APAC

South Korea
Japan
Australia

Latin America

Brazil
Argentina

MEA

Turkey
Israel
South Africa

Major Vendors

Mylan
Teva Pharmaceutical Industries
Amneal Pharmaceuticals

Other vendors include - Adamis Pharmaceuticals, ALK-Abelló, Bioprojet PHARMA, Bausch & Lomb, kaléo, and Novartis.

Explore our healthcare & lifesciences profile to know more about the industry.

Read some of the top-selling reports:

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Mail: [email protected]
Call: +1-312-235-2040
+1-302-469-0707

SOURCE Arizton Advisory & Intelligence